Diabete test kit Epithod® GA

hemoglobinmicroalbuminalbumin

Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control. World's first Glycated albumin test for Point-of-care Faster indicator in glycemic control Boronate Affinity Principle Why Glycated Albumin with HbA1c? Glycated Albumin is a kind of glycosylated protein and is the result of a covalent linkage between glucose and albumin. Similar to HbA1c, Glycated Albumin can be used to monitor long-term control of glucose in diabetics. It has a shorter half-life than HbA1c and is thought to be more sensitive to short-term fluctuations in glucose concentrations. Some HbA1c methods are affected by hemoglobin variants. Glycated Albumin is not subject to this interference. Glycated Albumin reflects average blood glucose concentration over the previous 2-4 weeks; used in the management of insulin therapy for diabetes mellitus. Glycated Albumin rapidly confirms treatment efficacy due to a shorter half-life than HbA1c. How is Microalbumin treated in diabetes? Diabetic nephropathy is a serious kidney-related complication of type 1 diabetes and types 2 diabetes. It is also called diabetic kidney disease. About 25% of people with diabetes eventually develop kidney disease. Diabetic nephropathy affects the kidneys' ability to do their usual work of removing waste products and extra fluid from the body.